306 results
Page 5 of 16
6-K
EX-99
e8xbwdjiv6h2kua1 37
16 Dec 20
Current report (foreign)
8:00am
6-K
EX-99
4x0j39
16 Dec 20
BioLineRx Announces Final Results from Phase 2a
6:02am
6-K
EX-99
7j72c239zzhbkppd
23 Nov 20
BioLineRx Reports Third Quarter 2020 Financial Results
7:08am
6-K
EX-99
ie2a1b1q4l8l
18 Nov 20
BioLineRx Announces Initiation of Phase 1b Clinical Trial
7:09am
424B5
def89vzbpwd9
13 Nov 20
Prospectus supplement for primary offering
4:31pm
6-K
EX-1
2bp4io6
30 Oct 20
BioLineRx Announces Positive Results from Interim Analysis of
7:09am
6-K
EX-99
zof4x3d
29 Oct 20
BioLineRx Announces Initiation of Phase 2 Clinical Trial
8:45am
6-K
EX-10.1
dpk8ddbwvge8iyn
25 Sep 20
Current report (foreign)
4:33pm
424B5
lii1uju92o5b20 ilt5t
25 Sep 20
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
jun7ra t4slt6b89
19 Aug 20
BioLineRx Achieves Enrollment Target in Phase 3
7:08am
POS AM
ydefvfv
10 Aug 20
Prospectus update (post-effective amendment)
12:00am
6-K
EX-99
uzuj2oyz5gc063bzk
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am
F-1
u8m8mqakociw
26 Jun 20
Registration statement (foreign)
4:30pm
424B5
i94dk07xk 2i7wxr
3 Jun 20
Prospectus supplement for primary offering
8:33am
6-K
uk4akd5olho5u1b
3 Jun 20
Current report (foreign)
8:30am
6-K
EX-99
hdxx ssad
3 Jun 20
Current report (foreign)
8:30am
6-K
EX-99
vhcsqf
1 Jun 20
BioLineRx Announces $4.39 Million Registered Direct Offering
8:05am
424B5
j2fh7dr4xza
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-99
ebiscw wfqf317o1v6eq
28 May 20
Current report (foreign)
11:56am
6-K
zqkh2
28 May 20
Current report (foreign)
11:56am